| Primary |
| Product Used For Unknown Indication |
23.5% |
| Drug Use For Unknown Indication |
12.2% |
| Pneumonia |
11.6% |
| Urinary Tract Infection |
6.9% |
| Meningitis |
5.3% |
| Prophylaxis |
4.8% |
| Infection |
4.1% |
| Cellulitis |
4.0% |
| Pain |
3.2% |
| Pyrexia |
3.1% |
| Upper Respiratory Tract Infection |
2.9% |
| Whipple's Disease |
2.4% |
| Bronchitis |
2.2% |
| Sepsis |
2.2% |
| Lyme Disease |
2.1% |
| Abdominal Infection |
2.0% |
| Sinusitis |
2.0% |
| Tenosynovitis |
2.0% |
| Meningitis Bacterial |
1.8% |
| Osteomyelitis |
1.8% |
|
| Anaphylactic Shock |
12.3% |
| Urticaria |
11.3% |
| Rash |
10.0% |
| Vomiting |
8.3% |
| Toxic Epidermal Necrolysis |
7.4% |
| Cholelithiasis |
6.6% |
| Renal Failure Acute |
6.6% |
| Pyrexia |
4.4% |
| Pruritus |
3.2% |
| Syncope |
3.2% |
| Thrombocytopenia |
3.2% |
| Dyspnoea |
2.9% |
| Haemolytic Anaemia |
2.9% |
| Injection Site Pain |
2.7% |
| Wheezing |
2.7% |
| Drug Hypersensitivity |
2.5% |
| Erythema |
2.5% |
| Stevens-johnson Syndrome |
2.5% |
| Tubulointerstitial Nephritis |
2.5% |
| Unresponsive To Stimuli |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
35.6% |
| Drug Use For Unknown Indication |
16.6% |
| Pneumonia |
8.2% |
| Pyrexia |
5.8% |
| Hypertension |
4.5% |
| Urinary Tract Infection |
3.6% |
| Bacteraemia |
3.3% |
| Infection |
2.7% |
| Sepsis |
2.7% |
| Lung Disorder |
1.8% |
| Meningococcal Sepsis |
1.8% |
| Pain |
1.7% |
| Depression |
1.7% |
| Hiv Infection |
1.7% |
| Staphylococcal Infection |
1.5% |
| Foetal Exposure During Pregnancy |
1.4% |
| Maternal Exposure Timing Unspecified |
1.4% |
| Septic Shock |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Cardiac Failure |
1.3% |
|
| Toxic Epidermal Necrolysis |
11.6% |
| Renal Failure Acute |
8.2% |
| Vomiting |
7.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
7.7% |
| Rash |
6.9% |
| Ureteric Obstruction |
5.8% |
| Neutropenia |
4.8% |
| Stevens-johnson Syndrome |
4.8% |
| Thrombocytopenia |
4.8% |
| Somnolence |
4.5% |
| Clostridium Difficile Colitis |
3.7% |
| Drug Ineffective |
3.7% |
| Respiratory Rate Increased |
3.7% |
| Urinary Tract Infection |
3.4% |
| Urticaria |
3.4% |
| Clostridial Infection |
3.2% |
| Renal Failure |
3.2% |
| Cardiac Arrest |
2.9% |
| Eosinophilic Pneumonia |
2.9% |
| Tachycardia |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.3% |
| Drug Use For Unknown Indication |
20.1% |
| Prophylaxis |
5.9% |
| Pneumonia |
3.8% |
| Rheumatoid Arthritis |
3.2% |
| Hypertension |
2.9% |
| Pain |
2.6% |
| Hiv Infection |
2.5% |
| Infection |
2.4% |
| Pyrexia |
2.4% |
| Infection Prophylaxis |
2.3% |
| Sepsis |
2.0% |
| Adverse Event |
1.6% |
| Urinary Tract Infection |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Multiple Myeloma |
1.4% |
| Diabetes Mellitus |
1.3% |
| Constipation |
1.3% |
| Convulsion |
1.2% |
| Premedication |
1.0% |
|
| Vomiting |
10.8% |
| Renal Failure |
8.4% |
| Thrombocytopenia |
7.6% |
| Sepsis |
6.9% |
| Renal Failure Acute |
6.2% |
| Urinary Tract Infection |
5.4% |
| Pyrexia |
5.1% |
| Pulmonary Embolism |
4.8% |
| White Blood Cell Count Increased |
4.7% |
| Pneumonia |
4.6% |
| Death |
4.3% |
| Supraventricular Tachycardia |
4.0% |
| Rhabdomyolysis |
3.9% |
| Septic Shock |
3.7% |
| Respiratory Failure |
3.5% |
| Neutropenia |
3.3% |
| Renal Tubular Necrosis |
3.3% |
| Stevens-johnson Syndrome |
3.2% |
| Weight Decreased |
3.2% |
| Toxic Epidermal Necrolysis |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
37.3% |
| Pneumonia |
10.6% |
| Atrial Fibrillation |
7.0% |
| Hypertension |
6.3% |
| Septic Shock |
4.2% |
| Urinary Tract Infection |
4.2% |
| Evidence Based Treatment |
2.8% |
| Heart Transplant |
2.8% |
| Lung Disorder |
2.8% |
| Productive Cough |
2.8% |
| Pyrexia |
2.8% |
| Renal Failure Chronic |
2.8% |
| Gastritis |
2.1% |
| Hypokalaemia |
2.1% |
| Osteomyelitis |
2.1% |
| Acute Pulmonary Oedema |
1.4% |
| Allergic Granulomatous Angiitis |
1.4% |
| Anticoagulant Therapy |
1.4% |
| Endocarditis Bacterial |
1.4% |
| Infection |
1.4% |
|
| Drug Interaction |
31.3% |
| International Normalised Ratio Increased |
12.5% |
| Eosinophilic Pneumonia |
6.3% |
| Immunosuppressant Drug Level Increased |
6.3% |
| Loss Of Consciousness |
6.3% |
| Overdose |
6.3% |
| Abdominal Wall Haematoma |
3.1% |
| Agranulocytosis |
3.1% |
| Allergic Granulomatous Angiitis |
3.1% |
| Anaemia |
3.1% |
| Cholestasis |
3.1% |
| Myocardial Infarction |
3.1% |
| Nephritis |
3.1% |
| Occult Blood Positive |
3.1% |
| Torsade De Pointes |
3.1% |
| Urinary Tract Infection |
3.1% |
|
